
Premium Sodium Laurate biocidal active for industrial and hygiene protection. High purity and efficacy guaranteed by Zyntex.
Sodium Laurate is a high-potency Active Pharmaceutical Ingredient (API) supplied by Zyntex, a global leader in pharmaceutical raw material distribution. Manufactured under stringent GMP (Good Manufacturing Practice) guidelines, this product (CAS 629-25-4) meets the rigorous monographs of the USP (United States Pharmacopeia), EP (European Pharmacopoeia), and BP (British Pharmacopoeia). We provide comprehensive regulatory support, including Drug Master Files (DMF) and Certificates of Analysis (CoA), to facilitate seamless drug registration and formulation.
As a cornerstone of modern pharmacotherapy, Sodium Laurate is engineered for exceptional purity and stability. Its precise chemical structure ensures optimal bioavailability and target receptor affinity, making it a critical component in the development of efficacious therapeutic agents. The synthesis process involves advanced purification techniques such as crystallization and chromatography to eliminate related substances and residual solvents, achieving a purity profile that often exceeds pharmacopoeial requirements.
Zyntex understands the critical nature of supply chain security in the pharmaceutical industry. Our Sodium Laurate is sourced from audited facilities that prioritize quality control at every step, from raw material procurement to final packaging. Rigorous testing for elemental impurities (ICH Q3D), residual solvents (ICH Q3C), and microbial limits ensures patient safety and product integrity.
This API is available in various particle size distributions (micronized or standard) to suit specific formulation needs, whether for oral solid dosage forms, injectables, or topical preparations. Its robust stability profile under accelerated conditions provides confidence in shelf-life determination for finished drug products.
Serving the forefront of medical science, Sodium Laurate is essential for:
The primary active ingredient for manufacturing generic and branded medications (tablets, capsules, syrups) targeting specific therapeutic indications.
A high-purity reference standard for analytical method development, bioequivalence studies, and early-stage drug discovery.
Used in the formulation of veterinary drugs to treat diseases and improve health outcomes in livestock and companion animals.
Enables pharmacists to create personalized medications with precise dosages for patients with unique needs or allergies.
| Parameter | Specification Standard |
|---|---|
| Product Name | Sodium Laurate |
| Standard | USP / EP / BP / IP |
| CAS Number | 629-25-4 |
| Purity (Assay) | ≥ 99.0% (HPLC) |
| Appearance | White or Off-White Crystalline Powder |
| Related Substances | Complies with Pharmacopoeia Limits |
| Water Content | Strictly Controlled (Karl Fischer) |
🔬 Regulatory & Scientific Data: For detailed pharmacokinetics, safety data sheets (SDS), and chemical structure, please consult:
PubChem Compound Summary: Sodium Laurate (External Link)